combretastatin has been researched along with Melanoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andronache, IC; Biersack, B; Kalie, H; Kaps, L; Muenzner, JK; Sasse, F; Schobert, R; Schuppan, D | 1 |
Chen, Z; Deng, C; Feng, L; Li, C; Long, Y; Su, T; Zhang, X | 1 |
Kiziltepe, T; Sasisekharan, R; Sengupta, S | 1 |
3 other study(ies) available for combretastatin and Melanoma
Article | Year |
---|---|
Gold(I) biscarbene complexes derived from vascular-disrupting combretastatin A-4 address different targets and show antimetastatic potential.
Topics: Actin Cytoskeleton; Animals; Antineoplastic Agents; Bibenzyls; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Drug Resistance, Neoplasm; G2 Phase Cell Cycle Checkpoints; Gold; HT29 Cells; Human Umbilical Vein Endothelial Cells; Humans; MCF-7 Cells; Melanoma; Methane; Mice; Mice, Inbred BALB C; Neovascularization, Physiologic; Tubulin | 2014 |
Construction of a two-in-one liposomal system (TWOLips) for tumor-targeted combination therapy.
Topics: Animals; Antineoplastic Agents; Bibenzyls; Doxorubicin; Drug Combinations; Drug Delivery Systems; Drug Stability; Drug Storage; Female; Humans; Liposomes; Male; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Particle Size; Silicon Dioxide; Survival Rate; Xenograft Model Antitumor Assays | 2014 |
A dual-color fluorescence imaging-based system for the dissection of antiangiogenic and chemotherapeutic activity of molecules.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Bibenzyls; Cell Line, Tumor; Coculture Techniques; Doxorubicin; Extracellular Matrix; Fluorescence; Hepatocyte Growth Factor; Humans; Melanoma; Neoplasms; Neovascularization, Pathologic; Phthalazines; Pyridines; Stilbenes; Thalidomide; Vascular Endothelial Growth Factor A | 2004 |